4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | Mandos LLC | 56 | 2015-10-01 | 2023-02-22 |
| Optimizing Protein Intake in Older Americans With Mobility Limitations Testosterone enanthate - Mobility Limitation | Phase 3 | Completed | Brigham and Women's Hospital | 92 | 2011-05-01 | 2021-07-29 |
| Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease Laser light (U-Step Walking Stabilizer with laser light) - Parkinson Disease | Phase 3 | Completed | Parkinson's Disease Research, Education, and Clinical Center, Philadelphia | 22 | 2003-06-01 | 2012-01-02 |
| A Comparison of Weighted Vest Exercise and Strength Training InVEST (Increased Velocity Exercise Specific to Task) - Mobility Limitations, Aging | Phase 3 | Completed | National Institute on Aging (NIA) | 160 | 2001-07-01 | 2010-07-26 |
Cognitive Dysfunction (1) · Deglutition Disorders (1) · Disease (1) · Niemann-Pick Disease, Type C (1) · Parkinson Disease (1)
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Brain Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Basal Ganglia Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1)
2-Hydroxypropyl-beta-cyclodextrin (1) · Cyclodextrins (1) · Lasers (1) · testosterone enanthate (1)
Brigham and Women's Hospital (1) · Mandos LLC (1) · National Institute on Aging (NIA) (1) · Parkinson's Disease Research, Education, and Clinical Center, Philadelphia (1)
United States (4) · Australia (1) · France (1) · Germany (1) · New Zealand (1) · Singapore (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Jonathan F. Bean, MD, MS (1) · Lisette Bunting-Perry, PhD, RN (1) · Shalender Bhasin, MD (1)
PMID 19414509, PMID 19854420, PMID 21143443, PMID 21636073, PMID 22289248, PMID 29188864, PMID 29532075, PMID 30932132, PMID 33417663, PMID 40525490
2015 (1), K23AG019663 (1), R01AG037547 (1)